Coronary interventions First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis Suwannasom P, Sotomi Y, Corti R, Kurz D, Roffi M, von Birgelen C, Buzzi S, Zucker A, Dijkstra J, Wykrzykowska J, de Winter R, Windecker S, Onuma Y, Serruys P, Daemen J, Räber L April 20, 2017 | 10.4244/EIJ-D-16-00975
Coronary interventions Ultra-hydrophilic stent platforms promote early vascular healing and minimise late tissue response: a potential alternative to second-generation drug-eluting stents Kolandaivelu K, Bailey L, Buzzi S, Zucker A, Milleret V, Ziogas A, Ehrbar M, Khattab A, Stanley J, Wong G, Zani B, Markham P, Tzafriri A, Bhatt D, Edelman E April 20, 2017 | 10.4244/EIJ-D-15-00497
New issue Discover the Special Edition on valvular heart disease prepared for PCR London Valves (3D-TEE model - Optimal implantation) November 15, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019
JAA This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more December 3, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial Medical device regulation in Europe – what is changing and how can I become more involved? October 18, 2019